Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Renal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03006887
What this trial is testing

Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors

Who this might be right for
Solid Tumors
Eisai Co., Ltd. 6
Early research (Phase 1)Study completedNCT05861778
What this trial is testing

Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaSuspected Recurrent Renal Clear Cell CarcinomaRecurrent Renal Cell Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 10
Not applicableUnknownNCT00757614
What this trial is testing

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more
Cancer Research UK 14,000
Testing effectiveness (Phase 2)Study completedNCT01835158
What this trial is testing

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 157
Testing effectiveness (Phase 2)Study completedNCT02978404
What this trial is testing

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Who this might be right for
Clear-Cell Metastatic Renal Cell CarcinomaNon Small Cell Lung Cancer MetastaticBrain Metastases, Adult+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741617
What this trial is testing

A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma

Who this might be right for
Urologic Neoplasms
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT03092856
What this trial is testing

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CancerRecurrent Renal Cell Carcinoma+1 more
University of Southern California 62
Early research (Phase 1)Study completedNCT01061411
What this trial is testing

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 16
Very early researchActive Not RecruitingNCT06318871
What this trial is testing

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

Who this might be right for
Renal CarcinomaRenal Cell CarcinomaUrothelial Carcinoma+2 more
Dana-Farber Cancer Institute 5
Not applicableLooking for participantsNCT05753839
What this trial is testing

The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial

Who this might be right for
Kidney CancerClear Cell Renal Cell Carcinoma MetastaticSynchronous Neoplasm
Yonsei University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07840001
What this trial is testing

Neoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Locally Advanced Clear Cell Renal Cell Carcinoma
Peter MacCallum Cancer Centre, Australia 30
Testing effectiveness (Phase 2)UnknownNCT03592199
What this trial is testing

Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib

Who this might be right for
Clear Cell Renal Cell Carcinoma
Instituto do Cancer do Estado de São Paulo 7
Testing effectiveness (Phase 2)Study completedNCT04118855
What this trial is testing

Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Neoadjuvant Therapy of Non-metastatic Locally Advanced Renal Cell Carcinoma
RenJi Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05899049
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 251
Large-scale testing (Phase 3)WithdrawnNCT01762592
What this trial is testing

REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Heidelberg Pharma AG
Testing effectiveness (Phase 2)Study completedNCT00979966
What this trial is testing

Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib

Who this might be right for
Non-clear Cell Renal Cell Cancer
Central European Society for Anticancer Drug Research 22
Testing effectiveness (Phase 2)Looking for participantsNCT06683846
What this trial is testing

Ivonescimab in the Treatment of Multiple Advanced Tumors

Who this might be right for
Pheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more
Fudan University 400
Early research (Phase 1)Study completedNCT00418496
What this trial is testing

Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma

Who this might be right for
Renal CancerMelanoma
Ohio State University Comprehensive Cancer Center 17
Very early researchStudy completedNCT05188118
What this trial is testing

Rapid Sequencing of Approved Therapies in Patients With Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Icahn School of Medicine at Mount Sinai 10
Testing effectiveness (Phase 2)Looking for participantsNCT06625190
What this trial is testing

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaSynovial Sarcoma+11 more
University of Florida 27
Next Page